The effects of Immunoglobulin M (IgM) enriched immunoglobulin preparations in patients with severe sepsis

Completed

• Conditions: Severe sepsis; Infections and Infestations; Sepsis

• Registration Number: ISRCTN28863830
• Lead Sponsor: Istanbul University (Turkey)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2002-04-29
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 39

Inclusion Criteria

Thirty-nine patients with severe sepsis, defined as:
1. Temperature of greater than 38°C or less than 36°C
2. Heart rate of greater than 90 beats/min
3. Respiratory rate greater than 20/min or arterial carbon dioxide pressure (PaCO2) less than 32 mmHg
4. White blood cell count greater than 12000/mm^3 or less than 4000/mm^3
5. Documented infection and dysfunction of an organ or hypotension

Exclusion Criteria

Does not comply with above inclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified